C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 495/04 (2006.01) A61K 31/395 (2006.01) A61K 31/407 (2006.01) A61K 31/427 (2006.01) A61K 31/454 (2006.01) A61K 31/5377 (2006.01) A61K 31/695 (2006.01) C07D 209/52 (2006.01) C07D 487/04 (2006.01) C07D 491/04 (2006.01) C07D 491/048 (2006.01) C07D 495/14 (2006.01) C07D 519/00 (2006.01) C07F 7/10 (2006.01)
Patent
CA 2321379
This invention relates to compounds of Formula I Image or stereoisomers, pharmaceutically acceptable salts or prodrugs thereof or a pharmaceutically acceptable salts of the prodrugs. This invention also relates to pharmaceutical compositions comprising a compound of Formula I, and to methods of treatment of diabetes, insulin resistance, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, cataracts, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemia, hyperlipidemia, atherosclerosis, or tissue ischemia.
Bereskin & Parr
Pfizer Products Inc.
LandOfFree
Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1821865